Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Fexofenadine Hydrochloride Tablets

Approval Number

国药准字H20153221

Company成都盛迪医药有限公司

Registration Date

August 12, 2020

Drug Information

Generic Name

盐酸非索非那定片

Trade Name

瑞菲

Brand Name

瑞菲

Dosage Form

片剂

Strength

60mg

Drug Type

化学药品

Registration Date

August 12, 2020

Company Information

Applicant Company

Company Name成都盛迪医药有限公司

Company Address

四川省成都市高新区康平路88号

Manufacturing Company

Company Name成都盛迪医药有限公司

Company Address

成都市高新区康平路88号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

盐酸非索非那定片 - NMPA 批准文号 | MedPath